Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ob/Gyn Panel Unanimously Supports Adhesion-Prevention Product Approval

This article was originally published in The Gray Sheet

Executive Summary

Baxter's biosurgery business stands to gain from an FDA advisory panel's unanimous support for a product designed to prevent a serious side effect of certain surgical procedures. But limitations recommended for the label could curb some of the market potential if adopted by the agency in its final approval decision
Advertisement

Related Content

Tyco Acquires Bio-Sealant Pipeline With $245 Mil. Confluent Surgical Buy
Tyco Acquires Bio-Sealant Pipeline With $245 Mil. Confluent Surgical Buy
FDA Panel To Decide If Adept Adhesion Prevention Device Is True To Its Name
FDA Panel To Decide If Adept Adhesion Prevention Device Is True To Its Name
Advertisement
UsernamePublicRestriction

Register

MT023398

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel